ECHA has contracted a consortium led by the Fraunhofer Institute for Toxicology & Experimental Medicine (ITEM) to conduct scientific studies on the reliability and relevance of new approach methodologies (NAMs) as alternatives to animal testing and to promote their use. This will run for six years, with €4.2 million in ECHA funding.